EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

NGF in Neuropathic Pain: Understanding Its Role and Therapeutic Opportunities

Mario García-Domínguez

Current Issues in Molecular Biology · 31.01.2025 · 47 (2) · 93

DOI: 10.3390/cimb47020093 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 31.01.2025. Verfasst von Mario García-Domínguez. Beteiligte Einrichtung: Program of Immunology and Immunotherapy, CIMA-Universidad de Navarra, 31008 Pamplona, Spain. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 182 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nerve growth factor (NGF) is one of the essential components that have been implicated in the pathophysiology of neuropathic pain, a condition that develops following nerve injury or dysfunction. This neurotrophin is critical for the survival and maintenance of sensory neurons, and its dysregulation has been implicated in the sensitization of pain pathways. NGF interacts with its receptor TrkA and p75NTR to activate intracellular signaling pathways associated with nociception and the emergence of allodynia and hyperalgesia. Therapeutic approaches employing neutralizing antibodies and molecule inhibitors have been highly effective at both preclinical and clinical levels, hence giving hope again for the use of NGF as an important biomarker and therapeutic target in the management of neuropathic pain. By exploiting the unique properties of NGF and its interactions within the nervous system, new therapeutic modalities could be designed to enhance efficacy while minimizing side effects. In conclusion, taking advantage of the multifaceted dynamics of NGF could provide effective pain management therapies to finally respond to the unmet needs of patients experiencing neuropathic pain.

Schlagwörter

Stichwörter der Autor:innen

analgesianerve growth factorneuropathic painneurotrophin

Autor:innen und Institutionen

  • Program of Immunology and Immunotherapy, CIMA-Universidad de Navarra, 31008 Pamplona, Spain.
  • Department of Immunology and Immunotherapy, Clínica Universidad de Navarra, 31008 Pamplona, Spain.
  • Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain.

Zitieren

APA

García-Domínguez, M. (2025). NGF in Neuropathic Pain: Understanding Its Role and Therapeutic Opportunities. Current Issues in Molecular Biology, 47(2), 93. https://doi.org/10.3390/cimb47020093

Vancouver

García-Domínguez M. NGF in Neuropathic Pain: Understanding Its Role and Therapeutic Opportunities. Current Issues in Molecular Biology. 2025;47(2):93. doi:10.3390/cimb47020093

BibTeX
@article{GarcaDomnguez2025,
  author = {García-Domínguez, Mario},
  title = {NGF in Neuropathic Pain: Understanding Its Role and Therapeutic Opportunities},
  journal = {Current Issues in Molecular Biology},
  year = {2025},
  volume = {47},
  number = {2},
  pages = {93},
  doi = {10.3390/cimb47020093}
}
Kostenlos starten →